Literature DB >> 14511654

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells.

Jerzy-Roch Nofer1, Sven Geigenmüller, Christian Göpfert, Gerd Assmann, Eckhart Buddecke, Annette Schmidt.   

Abstract

Adhesion and recruitment of blood monocytes, processes mediated by cell adhesion molecules including E-selectin, represent an early event in atherogenesis. High density lipoproteins (HDLs) were shown to inhibit cytokine-induced expression of adhesion molecules, but mechanisms underlying this effect are not fully understood. We here investigated the effects of sphingosylphosphorylcholine (SPC) and lysosulfatide (LSF), two lysosphingolipids associated with HDL, on TNF-alpha-induced E-selectin expression in human umbilical endothelial cells. We found that HDL, SPC, and LSF inhibited E-selectin expression both on mRNA and protein level. In addition, all three agents reduced the number of E-selectin molecules present on endothelial cell surface. The inhibitory effects of HDL, SPC, and LSF on TNF-alpha-induced E-selectin expression were partially reverted in the presence of suramin, an antagonist of lysosphingolipid receptor EDG-3, or pertussis toxin, an inhibitor of trimeric G proteins. In addition, inhibition of activation of protein kinase Akt with LY294002 but not inhibition of phosphatidylinositol-specific phospholipase C (PI-PLC) with U73122 abolished the restrictive effects of HDL-, SPC-, or LSF on E-selectin expression. We conclude that HDL-associated lysosphingolipids may at least partially account for the inhibitory effects of HDL on cytokine-induced expression of adhesion molecules, and that activations of G-protein-coupled receptors and protein kinase Akt are involved in this process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511654     DOI: 10.1016/j.bbrc.2003.08.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 3.  Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.

Authors:  Mirjam Schuchardt; Markus Tölle; Jasmin Prüfer; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 4.  Lipoproteins in inflammation and sepsis. I. Basic science.

Authors:  Oliver Murch; Marika Collin; Charles J Hinds; Christoph Thiemermann
Journal:  Intensive Care Med       Date:  2006-11-09       Impact factor: 17.440

5.  HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production.

Authors:  Markus Tölle; Alicja Pawlak; Miriam Schuchardt; Akira Kawamura; Uwe J Tietge; Stefan Lorkowski; Petra Keul; Gerd Assmann; Jerold Chun; Bodo Levkau; Markus van der Giet; Jerzy-Roch Nofer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-15       Impact factor: 8.311

Review 6.  The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions.

Authors:  Jérôme Robert; Elena Osto; Arnold von Eckardstein
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

7.  Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.

Authors:  Ruben van Doorn; Melissa A Lopes Pinheiro; Gijs Kooij; Kim Lakeman; Bert van het Hof; Susanne M A van der Pol; Dirk Geerts; Jack van Horssen; Paul van der Valk; Elizabeth van der Kam; Eric Ronken; Arie Reijerkerk; Helga E de Vries
Journal:  J Neuroinflammation       Date:  2012-06-20       Impact factor: 8.322

8.  Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.

Authors:  Christine Herzog; Martina Schmitz; Bodo Levkau; Ilka Herrgott; Jan Mersmann; Jan Larmann; Kai Johanning; Michael Winterhalter; Jerold Chun; Frank Ulrich Müller; Frank Echtermeyer; Reinhard Hildebrand; Gregor Theilmeier
Journal:  Mediators Inflamm       Date:  2011-01-03       Impact factor: 4.711

Review 9.  Emerging therapeutic strategies to enhance HDL function.

Authors:  Santiago Redondo; José Martínez-González; Concha Urraca; Teresa Tejerina
Journal:  Lipids Health Dis       Date:  2011-10-10       Impact factor: 3.876

Review 10.  Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.

Authors:  Giuseppe D Norata; Alberico L Catapano
Journal:  Vasc Health Risk Manag       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.